The International Association for the Study of Lung cancer (IASLC) 7th edition provide the most updated resource for lung cancer staging. This article provides a basic framework for TNM lung cancer staging.
See also - non small cell lung cancer staging
T staging descriptor
The parameter asse...
The Masaoka staging system is commonly adopted for thymomas 1-3, and is the most important determinant of survival following surgical resection 4:
stage I: intact thymic capsule
stage II: capsular invasion into adjacent mediastinal fat or pleura
stage III: macroscopic invasion into adjacent o...
Non-small cell lung cancer (NSCLC) staging can be accomplished both by the TNM system, or by the AJCC staging system.
For a general discussion of these tumours please refer to the article on non-small cell lung cancer (NSCLC).
The current 7th edition January 2010 NSCLC staging is ...
Oesophageal cancer staging can depend slightly on whether the tumour is squamous cell or adenocarcinoma subtype. Due to the lack of a serosal layer, oesophageal cancer often tends to have mediastinal spread at the time of diagnosis.
Tx: primary tumour cannot be...
Silzbach system is a chest radiographic staging method for sarcoidosis.
stage 0: normal chest radigraph: 10% at time of diagnosis
stage I: lymph node enlargement: 50% at time of diagnosis
stage II: lymph node enlargement and pulmonary opacities: 30% at time of diagnosis
stage III: pulmonary ...
Previously, small cell lung cancer was not staged in the same manner as non small cell lung cancer, on account of it almost never being resectable at the time of diagnosis, except in rare cases where it appears as a solitary pulmonary nodule.
disease confined to one hemithorax
A number of staging systems have been described for staging of malignant pleural mesothelioma. Below is the International Mesothelioma Interest Group TNM staging system.
T - Tumour
Tx: primary tumour cannot be assessed
T0: no evidence of primary tumour